Compare Stocks → Bombshell 2024 election documentary (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:CIMNYSE:EQCNYSE:NHINYSE:TWONYSE:WRI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIMChimera Investment$4.61+1.5%$4.57$4.17▼$6.49$1.11B1.682.06 million shs1.21 million shsEQCEquity Commonwealth$18.88+0.4%$18.87$17.93▼$21.49$2.02B0.241.02 million shs759,054 shsNHINational Health Investors$62.83+1.6%$56.76$47.54▼$62.93$2.73B0.94186,993 shs199,585 shsTWOTwo Harbors Investment$13.24+0.6%$12.85$9.83▼$14.72$1.37B1.871.11 million shs1.52 million shsWRIWeingarten Realty Investors$31.44$31.75$15.24▼$34.24$4.01B1.571.25 million shs26.46 million shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIMChimera Investment+1.21%-0.11%+5.49%-7.62%-19.26%EQCEquity Commonwealth+0.40%-0.97%+2.28%-1.67%-6.35%NHINational Health Investors+1.63%+1.26%+6.76%+12.50%+24.07%TWOTwo Harbors Investment+0.57%+1.46%+4.09%-4.95%-6.89%WRIWeingarten Realty Investors0.00%0.00%0.00%0.00%0.00%Bombshell 2024 election documentary (Ad)2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.All the facts are here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCIMChimera Investment4.4399 of 5 stars2.03.01.73.22.00.83.8EQCEquity Commonwealth2.3665 of 5 stars0.05.00.00.02.02.51.9NHINational Health Investors4.0106 of 5 stars1.32.01.74.13.13.31.9TWOTwo Harbors Investment1.9075 of 5 stars2.13.01.70.03.02.50.6WRIWeingarten Realty InvestorsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIMChimera Investment2.00Hold$5.5019.31% UpsideEQCEquity CommonwealthN/AN/AN/AN/ANHINational Health Investors2.50Moderate Buy$60.38-3.91% DownsideTWOTwo Harbors Investment2.14Hold$14.6310.46% UpsideWRIWeingarten Realty InvestorsN/AN/AN/AN/ACurrent Analyst RatingsLatest TWO, NHI, CIM, EQC, and WRI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/22/2024TWOTwo Harbors InvestmentJonestradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold3/18/2024NHINational Health InvestorsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$64.00 ➝ $66.003/12/2024NHINational Health InvestorsBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$67.002/26/2024NHINational Health InvestorsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Outperform$57.00 ➝ $64.002/26/2024NHINational Health InvestorsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$55.00 ➝ $63.001/30/2024NHINational Health InvestorsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$69.00(Data available from 3/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIMChimera Investment$772.90M1.44$1.08 per share4.27$11.28 per share0.41EQCEquity Commonwealth$60.52M33.38$1.02 per share18.48$21.28 per share0.89NHINational Health Investors$319.83M8.53$4.97 per share12.64$29.13 per share2.16TWOTwo Harbors Investment$480.36M2.85$0.70 per share18.92$16.53 per share0.80WRIWeingarten Realty Investors$433.92M9.25$2.02 per share15.53$13.95 per share2.25Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIMChimera Investment$126.10M$0.2320.048.09N/A16.32%7.51%1.44%5/2/2024 (Estimated)EQCEquity Commonwealth$91.16M$0.7624.84∞1.77150.62%4.04%3.78%5/1/2024 (Estimated)NHINational Health Investors$135.65M$3.1320.0713.81N/A42.40%10.65%5.41%5/14/2024 (Estimated)TWOTwo Harbors Investment-$106.37M-$2.00N/A∞N/A-22.14%2.47%0.28%5/6/2024 (Estimated)WRIWeingarten Realty Investors$112.15M$1.6544.9117.182.7118.97%4.93%2.27%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCIMChimera Investment$0.449.54%-20.63%191.30%N/AEQCEquity CommonwealthN/AN/AN/AN/AN/ANHINational Health Investors$3.605.73%-6.54%115.02%N/ATWOTwo Harbors Investment$1.8013.60%+1.64%N/A N/AWRIWeingarten Realty Investors$0.922.93%N/A55.76%N/ALatest TWO, NHI, CIM, EQC, and WRI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/20/2024NHINational Health InvestorsQuarterly$0.906.34%3/27/20243/28/20245/3/20243/28/2024CIMChimera Investmentquarterly$0.119.54%4/5/20244/8/20244/30/20243/20/2024TWOTwo Harbors Investmentquarterly$0.4513.8%4/3/20244/4/20244/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIMChimera Investment3.000.120.12EQCEquity CommonwealthN/A79.7279.72NHINational Health Investors0.9010.2710.27TWOTwo Harbors Investment1.001.481.48WRIWeingarten Realty Investors1.001.621.58OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIMChimera Investment48.44%EQCEquity Commonwealth96.00%NHINational Health Investors62.51%TWOTwo Harbors Investment64.19%WRIWeingarten Realty Investors85.19%Insider OwnershipCompanyInsider OwnershipCIMChimera Investment0.74%EQCEquity Commonwealth2.80%NHINational Health Investors7.26%TWOTwo Harbors Investment0.45%WRIWeingarten Realty Investors6.60%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCIMChimera Investment39241.36 million239.58 millionOptionableEQCEquity Commonwealth22106.99 million104.00 millionOptionableNHINational Health Investors2643.41 million40.26 millionOptionableTWOTwo Harbors Investment466103.43 million102.96 millionOptionableWRIWeingarten Realty Investors243127.63 millionN/AOptionableTWO, NHI, CIM, EQC, and WRI HeadlinesSourceHeadlineAmerican Realty Investors Inc ARLmorningstar.com - November 8 at 2:35 PMFive Eye-Popping Truths Investors Need To Know About Manhattan Real Estateforbes.com - September 29 at 12:54 PMRandi Weingarten attack on DeSantis over education backfires: 'Literally closed every school in the country'msn.com - August 24 at 3:40 PMInvestors Edge Real Estatedomain.com.au - July 29 at 1:07 PMOn Randi Weingarten’s Waterfrontmsn.com - May 2 at 9:27 PMUFT loves charters . . . as long as Randi Weingarten is involvedmsn.com - April 28 at 9:19 PMTeachers Union President Randi Weingarten testifies before Congress on Covid-19 school closuresedsource.org - April 27 at 12:34 AMRandi Weingarten is the shame of the nationnypost.com - April 20 at 8:56 PMEllis Martin Report: The Astrologers Fund's Henry Weingarten-Yellow Alert!marketwatch.com - April 18 at 7:50 AMInvestors Retreat From Commercial Real Estate Bondswsj.com - April 8 at 12:18 PMLeft-wing antisemitism and Randi Weingarten’s Jewish conspiracy theorieswashingtontimes.com - April 4 at 6:44 PMHow to Start Investing in Real Estate: The Basicsfool.com - April 1 at 8:24 PMInvestors bought 1 in 4 homes in D-FW last year. Most were not big Wall Street firmsdallasnews.com - March 21 at 11:24 PMReal-estate investors said eliminating a popular tax-avoidance tool would damage the economybusinessinsider.com - March 18 at 1:21 PMUnderstanding the 1% rule for real estate investorsfinance.yahoo.com - March 12 at 6:54 PMWhat ESG Means for Real Estate Investorswealthmanagement.com - February 25 at 3:41 PMTCIseekingalpha.com - February 22 at 9:23 PMProperty investors may lose tax breaks in real estate reformstimesofisrael.com - February 18 at 7:06 PMTax Benefits for Active and Passive Real Estate Investorsmorningstar.com - January 27 at 11:08 PMEuropean investors cut allocations to real estate -surveyreuters.com - January 25 at 1:15 PMReal estate investors’ golden rules for an uncertain 2023heraldsun.com.au - January 25 at 8:15 AMReal Estate Syndicationbenzinga.com - January 12 at 8:09 PMThe 6 best podcasts for commercial real estate investors in 2023businessinsider.com - January 5 at 12:54 PMWho’s Afraid of Randi Weingarten?wsj.com - December 6 at 6:48 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines5 Undervalued AI Stocks and Why to Buy ThemMarch 20, 2024 7:41 AMView 5 Undervalued AI Stocks and Why to Buy ThemIs UnitedHealth Group Stock a Strong Buy or a Falling Knife?March 5, 2024 7:08 AMView Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?Unlock the Potential: Smart Strategies to Invest in CybersecurityMarch 15, 2024 10:01 AMView Unlock the Potential: Smart Strategies to Invest in CybersecurityThe Ozempic Diet Trend is Lifting These 2 Carnivore StocksMarch 4, 2024 6:28 AMView The Ozempic Diet Trend is Lifting These 2 Carnivore Stocks3 Hot Stocks Bought by Members of Congress: Follow the MoneyMarch 1, 2024 7:05 AMView 3 Hot Stocks Bought by Members of Congress: Follow the MoneyAll Headlines Company DescriptionsChimera InvestmentNYSE:CIMChimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities. It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.Equity CommonwealthNYSE:EQCEquity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's portfolio is comprised of four properties totaling 1.5 million square feet.National Health InvestorsNYSE:NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.Two Harbors InvestmentNYSE:TWOTwo Harbors Investment Corp. invests in, finances, and manages mortgage servicing rights (MSRs), agency residential mortgage-backed securities (RMBS), and other financial assets through RoundPoint in the United States. The company target assets include agency RMBS collateralized by fixed rate mortgage loans, adjustable rate mortgage loans, hybrid mortgage loans, or derivatives; and other assets, such as financial and mortgage-related assets, including non-agency securities and non-hedging transactions. It qualifies as a REIT for federal income tax purposes. As a REIT, the company must distribute at least 90% of annual taxable income to its stockholders. Two Harbors Investment Corp. was incorporated in 2009 and is headquartered in St. Louis Park, Minnesota.Weingarten Realty InvestorsNYSE:WRIWeingarten Realty Investors (NYSE: WRI) is a shopping center owner, manager and developer. At September 30, 2020, the Company owned or operated under long-term leases, either directly or through its interest in real estate joint ventures or partnerships, a total of 162 properties which are located in 15 states spanning the country from coast to coast. These properties represent approximately 31.0 million square feet of which our interests in these properties aggregated approximately 21.0 million square feet of leasable area. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.